Trial Profile
Efficacy and safety of daclatasvir plus asunaprevir treatment in chronic hepatitis C Japanese patients with renal dysfunction
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Sep 2017
Price :
$35
*
At a glance
- Drugs Asunaprevir (Primary) ; Daclatasvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 23 Sep 2017 New trial record